
Matricis.ai aims to democratize expert MRI care by developing medical-grade AI solutions to address challenges in radiology. Their initial focus is on endometriosis, a condition affecting 10% of women, often leading to a 7-year delay in diagnosis and a 75% misdiagnosis rate. Matricis.ai's AI technology seeks to improve diagnostic accuracy, reduce errors, save radiologists time, enhance reading comfort, and democratize specialized radiologist expertise. The company is founded by Raphaelle Taub (CEO), Arnaud Fanthomme (CTO), and Elise Mekkaoui (CPO).

Matricis.ai aims to democratize expert MRI care by developing medical-grade AI solutions to address challenges in radiology. Their initial focus is on endometriosis, a condition affecting 10% of women, often leading to a 7-year delay in diagnosis and a 75% misdiagnosis rate. Matricis.ai's AI technology seeks to improve diagnostic accuracy, reduce errors, save radiologists time, enhance reading comfort, and democratize specialized radiologist expertise. The company is founded by Raphaelle Taub (CEO), Arnaud Fanthomme (CTO), and Elise Mekkaoui (CPO).
Focus: AI for MRI in women's health (initial use-case: endometriosis)
Headquarters: Paris, France
Founded: 2022
Founders / leadership: Raphaelle Taub (CEO), Arnaud Fanthomme (CTO), Elise Mekkaoui (CPO)
Funding: One non-equity assistance round (Aug 1, 2023) — Agoranov
Medical imaging / radiology for women's health
2022
Biotechnology
Non-equity assistance round recorded on Aug 1, 2023
“Agoranov (lead in recorded non-equity assistance round); additional mentions in records include INRIA and an individual (Olivier Vaury) in investor/shareholder context”